Arbor Biotechnologies is advancing novel gene editing therapeutics to address a wide range of genetic diseases with a focus on diseases of high unmet need.
Base: $110,000 - $125,000; Bonus/Equity: Not specified; Benefits: Not specified
Must-have
Nice-to-have
Not specified